International Journal of Drug Policy
Volume 21, Issue 5 , Pages 437-439, September 2010

Misdirected opposition: Evidence opposing “not in my back yard” arguments against syringe exchange programmes

  • Chyvette T. Williams

      Affiliations

    • University of Illinois at Chicago, School of Public Health, 1603 West Taylor Street, MC923, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 312 996 4199; fax: +1 312 996 1450.
  • ,
  • Lawrence J. Ouellet

      Affiliations

    • University of Illinois at Chicago, School of Public Health, USA

Received 27 October 2009; received in revised form 26 January 2010; accepted 8 February 2010. published online 16 March 2010.

Abstract 

Background

Despite overwhelming evidence of their effectiveness, the establishment and maintenance of syringe exchange programmes (SEPs) in the US continue to draw opposition from community members, religious and political leaders, and law enforcement officials. One argument against SEPs is that they draw drug activity into the communities where they operate.

Methods

We use 8 years of survey data from participants attending an SEP in Chicago to explore this argument by reviewing responses (N=4827) to a question asking participants the main reason they spend time in the area.

Results

Findings show far more participants come to the area to buy drugs (60%) than to exchange needles (3.8%), and differences exist by ethnicity. More whites than blacks or Latinos reported being in the area primarily to buy drugs and use the SEP.

Conclusion

Re-directing opposition from SEPs to constructive ways of addressing fundamental causes of drug markets is recommended.

Keywords: Syringe exchange programmes, Illicit drug markets, Ethnicity, Harm reduction policy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(10)00017-4

doi:10.1016/j.drugpo.2010.02.003

International Journal of Drug Policy
Volume 21, Issue 5 , Pages 437-439, September 2010